EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Early Effects of Esketamine on the Tumor Metastatic Microenvironment in Postoperative Lung Cancer Patients

Yong Wang, Weijing Li, Li Jia, Junmei Shen, Chao Li, Huiqun Jia

The Clinical Respiratory Journal · 2025-08 · 19 (8)

DOI: 10.1111/crj.70108 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background To investigate the early effect of esketamine on the tumor metastatic microenvironment in patients with lung cancer. Methods Sixteen adults aged 45–80 years with the American Society of Anesthesiologists (ASA) 1 to 3 were randomly divided into the experimental group (group E) and the control group (group C). Group E received esketamine at 1 mg/kg during anesthesia induction and a continuous infusion of 0.5 mg/kg/h during the surgery. Group C was given the same amount of normal saline infusion. Patient‐controlled intravenous analgesia (PCIA) in group E was administered using dexmedetomidine (0.5 mg/kg) + esketamine (50 mg) + dexamethasone (5 mg). PCIA in group C was the same dose of dexmedetomidine and dexamethasone. Data were recorded at 14 points from admission to the third day after surgery (T 0–14 ). Parameters recorded included hemodynamics, wake time, remifentanil dosage, and so on. At T 0 , T 10 , T 13 , and T 14 , TNF‐α, IL‐2, IL‐10, MMP‐9, and VEGF‐C were measured. Results Compared with T 0 , the differences of tumor necrosis factor‐α (TNF‐α), interleukin‐2 (IL‐2), matrix metallopeptidase 9 (MMP‐9), and vascular endothelial growth factor‐C (VEGF‐C) in the two groups were statistically significant ( p < 0.05). When compared to group C, VEGF‐C in group E was reduced at T 10 and T 13 ( p < 0.05). For both groups, there were intragroup differences in the changes of MMP‐9 and VEGF‐C levels ( p < 0.05). Compared to group C, on the postoperative, group E exhibited a lower change rate of TNF‐α and VEGF‐C ( p < 0.05). Conclusion Perioperative application of esketamine in patients with lung cancer provided significant sedative and analgesic effects and affected cytokines in the tumor microenvironment.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →